62 related articles for article (PubMed ID: 5350783)
1. [Mechanism of action of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine on circulation. VII. Hypertension and bradycardia following cocaine pretreatment].
Sándor P; Kovách AG
Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):31-6. PubMed ID: 5350783
[No Abstract] [Full Text] [Related]
2. [Mechanism of action of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine on circulation. 8. Hypertensive effect following serotonin, nialamide, and pyrogallol pretreatment].
Kovách AG; Dóra E; Sandor P; Hajnal L
Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):37-46. PubMed ID: 5364256
[No Abstract] [Full Text] [Related]
3. [Studies on the mechanism of the venous tone increasing effect of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine].
Földi M; Zoltán OT
Z Kreislaufforsch; 1967 Mar; 56(3):272-4. PubMed ID: 5588086
[No Abstract] [Full Text] [Related]
4. [Mechanism of action of 2-ethyl-3,3-dipenyl-propen-(2)-yl-amine on blood circulation. V. Studies on hypophysectomized and nephrectomized cats].
Sándor P; Kovách AG
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):471-4. PubMed ID: 5360321
[No Abstract] [Full Text] [Related]
5. [Mechanism of action of 2-ethyl-3,3-diphenyl-propene-(2)-yl-amine on the circulation. VI. Effect on isolated smooth muscle in vitro].
Kovách AG; Sándor P; Pásztor A
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):263-72. PubMed ID: 5408588
[No Abstract] [Full Text] [Related]
6. The mechanism of hypotensive action of N-(2-(2-methoxyphenoxy) ethyl)-3-(2, 5-dimethoxyphenoxy) propylamine hydrochloride.
Bapna JS; Dandiya PC
Indian J Physiol Pharmacol; 1969 Jan; 13(1):47-51. PubMed ID: 4390897
[No Abstract] [Full Text] [Related]
7. [Comparative studies on the effect of 2-ethyl-3,3-diphenyl-propen (2)-yl-amine and adrenaline on the blood pressure, liver- and kidney circulation].
Kun E; Kunos G; Marton I; Kovách AG
Med Welt; 1968 May; 20():1298-301. PubMed ID: 5717758
[No Abstract] [Full Text] [Related]
8. [Pharmacology of diphenylalkyl-derivatives. IV. Pharmacology of a noradrenaline increasing effect of dephenylpropylamine-amine-derivatives].
Leszkovszky GP; Tardos L; Lendvai J; Takács K
Arzneimittelforschung; 1967 Dec; 17(12):1590-5. PubMed ID: 5633110
[No Abstract] [Full Text] [Related]
9. Cocaine acts in the central nervous system to inhibit sympathetic neural activity.
Raczkowski VF; Hernandez YM; Erzouki HK; Abrahams TP; Mandal AK; Hamosh P; Friedman E; Quest JA; Dretchen KL; Gillis RA
J Pharmacol Exp Ther; 1991 Apr; 257(1):511-9. PubMed ID: 2020007
[TBL] [Abstract][Full Text] [Related]
10. [Experimental animal studies on the effect of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine hydrochloride on blood pressure and activity of the cerebral cortex].
Weis A; Blösch M; Stausberg G
Med Welt; 1967 Mar; 10():580-3. PubMed ID: 5587142
[No Abstract] [Full Text] [Related]
11. [Gilutensin-Heptaminol in vegetative circulatory regulation disorders].
Aschke J; Trieb G; Nusser E
Med Klin; 1970 Oct; 65(43):1878-83. PubMed ID: 5476058
[No Abstract] [Full Text] [Related]
12. Antiarrhythmic effect of some naphthylalkylamine derivatives.
Hadházy P; Kecskeméti V; Vizi ES; Illés P
Acta Physiol Acad Sci Hung; 1968; 33(2):185-95. PubMed ID: 5679793
[No Abstract] [Full Text] [Related]
13. Role of the sympathetic nervous system in the cardiovascular effects of cocaine.
Gillis RA; Bachenheimer LC; Dretchen KL; Erzouki HK; Hernandez YM; Jain RK; Jain MK; Kuhn FE; Quest J; Schaer GL
NIDA Res Monogr; 1991; 108():92-109. PubMed ID: 1749420
[No Abstract] [Full Text] [Related]
14. 3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities.
Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Donnoli D; Stella L; Marmo E
Farmaco; 1990 Feb; 45(2):137-46. PubMed ID: 2133991
[TBL] [Abstract][Full Text] [Related]
15. The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans.
Collins ED; Vosberg SK; Ward AS; Haney M; Foltin RW
Exp Clin Psychopharmacol; 2007 Jun; 15(3):228-37. PubMed ID: 17563209
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological studies on 1-(para-chlorophenyl)-2-methyl-2-aminopropane hydrochloride].
Ciborska H; Darzynkiewicz-Czernik D; Mazur M; Polakowski P; Sobis H; Szadowska A
Acta Pol Pharm; 1969; 26(6):595-602. PubMed ID: 5380507
[No Abstract] [Full Text] [Related]
17. [Effect of 1-ethyl-4-(2-morpholinoethyl)-3, 3-diphenyl-2-pyrrolidinone hydrochloride hydrate (doxapram) on respiration and circulation].
Kubota T; Sasaki T; Nakazawa M
Nihon Yakurigaku Zasshi; 1974 Nov; 70(6):757-66. PubMed ID: 4533748
[No Abstract] [Full Text] [Related]
18. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
Kadatz R; Diederen W
Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
[No Abstract] [Full Text] [Related]
19. [Analeptic cardiorespiratory properties of the combination of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine-gluconate and heptaminol chlorhydrate].
La Barre J
Arzneimittelforschung; 1970 Apr; 20(4):515-9. PubMed ID: 4392907
[No Abstract] [Full Text] [Related]
20. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
Branch CA; Knuepfer MM
J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
